-
Dear readers, In my final post-ASCO GU 2025 newsletter, I wanted to reflect on some research hubs and important studies that I shared over the…
GU Oncology With Eleni Efstathiou, MD, PhD
UrologyDr. Eleni Efstathiou is a Professor of Cancer Medicine and GenitoUrinary Medical Oncology Section Chief at the Houston Methodist Cancer Center. She is known for her breakthrough translational research in prostate cancer. Dr Efstathiou’s main research focus is targeted novel therapeutics as tools to guide marker-driven treatment strategies in prostate cancer, and genomic and non-genomic pathways of resistance.
-
Key Prostate Cancer Updates from ASCO GU Symposium 2025 - 28 day(s) ago
Dear readers, The ASCO GU Cancers Symposium 2025 may be over, but there is still plenty of groundbreaking research to review in prostate cancer. First,…
-
Prostate Cancer Sessions Detailed at ASCO GU Symposium - 1 month(s) ago
Dear readers, A lot was covered in prostate cancer at the ASCO GU Symposium 2025. GU Oncology Now has been at the helm of coverage…
-
ASCO GU Symposium 2025: Updates in Prostate Cancer Coming Soon - 1 month(s) ago
Dear readers, Today kicks off the first day of the ASCO Genitourinary Cancers Symposium 2025, and I am looking forward to 3 days of thought-provoking…
-
Final Prostate Cancer Insights - 6 month(s) ago
Dear readers, To round out our series on prostate cancer at the ESMO Congress 2024, I included the final four segments of roundtable coverage where…
-
Hormone-Sensitive Disease and PEACE III - 6 month(s) ago
Dear readers, I am excited to share some segments from the prostate cancer roundtable from the ESMO Congress 2024. I joined a panel of experts…
-
Final Thoughts on ESMO 2024 - 6 month(s) ago
Dear readers, As always, this year’s ESMO Congress was an enriching event filled with breaking news and insightful conversation with colleagues from across the globe.…
-
Dear readers, The ESMO Congress 2024 kicks off today in Barcelona, Spain. I wanted to highlight some of the online buzz surrounding upcoming news in…